Publications
| Title | Abstract | Year Filter | PMID(sorted ascending) Filter |
|---|
| a critical role of gas6/axl signal in allergic airway responses during rsv vaccine-enhanced disease. | respiratory syncytial virus (rsv) is a common virus that causes lower respiratory infections across a wide range of ages. a licensed rsv vaccine is not available because vaccination with formalin-inactivated rsv (fi-rsv) and the subsequent rsv infection cause not only insufficient induction of neutralizing antibodies but also severe allergic airway responses, termed fi-rsv vaccine enhanced disease (fi-rsv ved). however, the underlying mechanism has not been identified, although a th2-biased immu ... | 2017 | 28722020 |
| prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus (rsv) infected infants. | longitudinal rsv dynamics have not been well-studied despite existence of factors favoring prolonged rsv replication including: high mutation rates allowing rapid evolution and potential escape from immune control. we therefore measured viral load in previously rsv-naïve infants over prolonged time-spans. | 2017 | 28723886 |
| human metapneumovirus and other respiratory viral infections during pregnancy and birth, nepal. | human metapneumovirus (hmpv) is a respiratory virus that can cause severe lower respiratory tract disease and even death, primarily in young children. the incidence and characteristics of hmpv have not been well described in pregnant women. as part of a trial of maternal influenza immunization in rural southern nepal, we conducted prospective, longitudinal, home-based active surveillance for febrile respiratory illness during pregnancy through 6 months postpartum. during 2011-2014, hmpv was dete ... | 2017 | 28726613 |
| promising approaches for the treatment and prevention of viral respiratory illnesses. | viral respiratory tract infections are the most common human ailments, leading to enormous health and economic burden. hundreds of viral species and subtypes have been associated with these conditions, with influenza viruses, respiratory syncytial virus, and rhinoviruses being the most frequent and with the highest burden. when considering prevention or treatment of viral respiratory tract infections, potential targets include the causative pathogens themselves but also the immune response, dise ... | 2017 | 28739285 |
| respiratory viruses in transplant recipients: more than just a cold. clinical syndromes and infection prevention principles. | the aim of this review is to provide updated information on the clinical spectrum, treatment options, and infection prevention strategies for respiratory viral infections (rvis) in both solid organ (sot) and hematopoietic stem cell transplant (hsct) patients. | 2017 | 28739424 |
| development of quality metrics for ambulatory pediatric cardiology: infection prevention. | in 2012, the american college of cardiology's (acc) adult congenital and pediatric cardiology council established a program to develop quality metrics to guide ambulatory practices for pediatric cardiology. the council chose five areas on which to focus their efforts; chest pain, kawasaki disease, tetralogy of fallot, transposition of the great arteries after arterial switch, and infection prevention. here, we sought to describe the process, evaluation, and results of the infection prevention co ... | 2017 | 28741863 |
| mammalian diaphanous-related formin-1 restricts early phases of influenza a/nws/33 virus (h1n1) infection in llc-mk2 cells by affecting cytoskeleton dynamics. | viruses depend on cellular machinery to efficiently replicate. the host cytoskeleton is one of the first cellular systems hijacked by viruses in order to ensure their intracellular transport and promote the development of infection. our previous results demonstrated that stable microfilaments and microtubules interfered with human influenza a/nws/33 virus (h1n1) infection in semi-permissive llc-mk2 cells. although formins play a key role in cytoskeletal remodelling, few studies addressed a possi ... | 2017 | 28744815 |
| investigation of respiratory syncytial virus outbreak on an adult stem cell transplant unit using whole genome sequencing. | a viral whole genome sequencing strategy, based on pcr amplification followed by next-generation sequencing, was used to investigate a nosocomial rsv-b outbreak in a hematology-oncology and stem cell transplant unit. rsv-b genomes from 16 patients and healthcare workers (hcws) suspected to be involved in the outbreak were compared to rsv-b genomes acquired from outpatients during the same time period but epidemiologically unrelated to the outbreak. phylogenetic analysis of the whole genome ident ... | 2017 | 28747373 |
| parainfluenza virus 5 (piv5) expressing wild-type or pre-fusion respiratory syncytial virus (rsv) fusion protein protect mice and cotton rats from rsv challenge. | human respiratory syncytial virus (rsv) is the leading cause of pediatric bronchiolitis and hospitalizations. rsv can also cause severe complications in elderly and immunocompromised individuals. there is no licensed vaccine. we previously generated a piv5-vectored vaccine candidate expressing the rsv fusion protein (f) that was immunogenic and protective in mice. in this work, our goal was to improve the original vaccine candidate by modifying the piv5 vector or by modifying the rsv-f antigen. ... | 2017 | 28747496 |
| the genetic stability of piv5-vectored rsv vaccine candidates after in vitro and in vivo passage. | human respiratory syncytial virus (rsv) is the leading etiologic agent of lower respiratory tract infections in children, but no licensed vaccine exists. previously, our laboratory developed two parainfluenza virus 5 (piv5)-based rsv vaccine candidates that protect mice against rsv challenge. piv5 was engineered to express either the rsv fusion protein (f) or the rsv major attachment glycoprotein (g) between the hn and l genes of the piv5 genome [piv5-rsv-f (hn-l) or piv5-rsv-g (hn-l)]. to inves ... | 2017 | 28747497 |
| cholesterol is required for stability and infectivity of influenza a and respiratory syncytial viruses. | cholesterol-rich lipid raft microdomains in the plasma membrane are considered to play a major role in the enveloped virus lifecycle. however, the functional role of cholesterol in assembly, infectivity and stability of respiratory rna viruses is not fully understood. we previously reported that depletion of cellular cholesterol by cholesterol-reducing agents decreased production of human parainfluenza virus type 1 (hpiv1) particles by inhibiting virus assembly. in this study, we analyzed the ro ... | 2017 | 28750327 |
| respiratory syncytial virus: a systematic scientometric analysis of the global publication output and the gender distribution of publishing authors. | worldwide, the respiratory syncytial virus (rsv) represents the predominant viral agent causing bronchiolitis and pneumonia in children. to conduct research and tackle existing healthcare disparities, rsv-related research activities around the globe need to be described. hence, we assessed the associated scientific output (represented by research articles) by geographical, chronological and socioeconomic criteria and analysed the authors publishing in the field by gender. also, the 15 most cited ... | 2017 | 28751483 |
| transient depletion of cd169(+) cells contributes to impaired early protection and effector cd8(+) t cell recruitment against mucosal respiratory syncytial virus infection. | respiratory syncytial virus (rsv) is a major cause of respiratory viral infections in infants and children. alveolar macrophages (ams) play a crucial role in combatting airborne pathogens, strongly express cd169, and are localized in the lung alveoli. therefore, we used cd169-diphtheria toxin receptor (dtr) transgenic mice to explore the roles of cd169(+) cells in immune responses to mucosal rsv infection. the administration of diphtheria toxin to cd169-dtr mice induced specific am depletion and ... | 2017 | 28751894 |
| camp-dependent activation of protein kinase a attenuates respiratory syncytial virus-induced human airway epithelial barrier disruption. | airway epithelium forms a barrier to the outside world and has a crucial role in susceptibility to viral infections. cyclic adenosine monophosphate (camp) is an important second messenger acting via two intracellular signaling molecules: protein kinase a (pka) and the guanidine nucleotide exchange factor, epac. we sought to investigate effects of increased camp level on the disruption of model airway epithelial barrier caused by rsv infection and the molecular mechanisms underlying camp actions. ... | 2017 | 28759570 |
| utility of ambulance data for real-time syndromic surveillance: a pilot in the west midlands region, united kingdom. | introduction the public health england (phe; united kingdom) real-time syndromic surveillance team (resst) currently operates four national syndromic surveillance systems, including an emergency department system. a system based on ambulance data might provide an additional measure of the "severe" end of the clinical disease spectrum. this report describes the findings and lessons learned from the development and preliminary assessment of a pilot syndromic surveillance system using ambulance dat ... | 2017 | 28760171 |
| therapeutic efficacy of a respiratory syncytial virus fusion inhibitor. | respiratory syncytial virus is a major cause of acute lower respiratory tract infection in young children, immunocompromised adults, and the elderly. intervention with small-molecule antivirals specific for respiratory syncytial virus presents an important therapeutic opportunity, but no such compounds are approved today. here we report the structure of jnj-53718678 bound to respiratory syncytial virus fusion (f) protein in its prefusion conformation, and we show that the potent nanomolar activi ... | 2017 | 28761099 |
| prevalence of respiratory viruses in wheezing children not older than 24 months of age. | wheezing in children not older than 24 months of age is a frequent event, and viruses are usually the causative agents. the aim of the study was to estimate the prevalence of respiratory viruses in wheezing children who were not older than 24 months of age and who had no history of asthma. | 2017 | 28763071 |
| [comparison of clinical features and diagnosis between the a and b subgroups of respiratory syncytial virus.] | lower respiratory tract infection by respiratory syncytial virus (rsv) is the most frequent cause of admission in children under 2 years old. the rsv subgroups a and b may circulate simultaneously. we aimed to determine whether clinical differences exist between rsv subgroups a and b. additionally, we tested the sensitivity of the rapid antigen detection test (radt) based on immunochromatography in diagnosing subgroups a and b, taking the polymerase chain reaction assay (rt-pcr) as reference. | 2017 | 28765656 |
| natural helper cells mediate respiratory syncytial virus-induced airway inflammation by producing type 2 cytokines in an il-33-dependent manner. | type 2 cytokine production during respiratory virus infection is considered to be linked with asthma exacerbation. as potent th2 cytokine producers, natural helper (nh) cells play a key role in influenza virus-induced airway hyper-responsiveness. however, it is unclear whether nh cells contribute to respiratory syncytial virus (rsv)-induced airway inflammation, and how the cytokine profile in nh cells is changed during rsv infection. | 2017 | 28771101 |
| the susceptibilities of respiratory syncytial virus to nucleolin receptor blocking and antibody neutralization are dependent upon the method of virus purification. | respiratory syncytial virus (rsv) that is propagated in cell culture is purified from cellular contaminants that can confound experimental results. a number of different purification methods have been described, including methods that utilize fast protein liquid chromatography (fplc) and gradient ultracentrifugation. thus, the constituents and experimental responses of rsv stocks purified by ultracentrifugation in sucrose and by fplc were analyzed and compared by infectivity assay, coomassie sta ... | 2017 | 28771197 |
| pulmonary c-fiber degeneration downregulates ifn-γ receptor 1 via ifn-α induction to attenuate rsv-induced airway hyperresponsiveness. | respiratory syncytial virus (rsv) is a leading cause of respiratory infection in infants. unfortunately, no effective vaccine or treatment against rsv is currently available. pulmonary c-fibers (pcfs) are critical for regulating pulmonary inflammation and airway hyperresponsiveness (ahr). we previously reported that ifn-γ partially mediated rsv-induced airway disorders. in this study, we found that pcf degeneration alleviated rsv-induced airway inflammation, especially ahr by downregulating ifn- ... | 2017 | 28772166 |
| prevalence and seasonality of six respiratory viruses during five consecutive epidemic seasons in belgium. | acute respiratory infections (aris) are a major health problem, especially in young children and the elderly. | 2017 | 28772168 |
| discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial virus(rsv) fusion inhibitors. | recently we described a novel class of imidazopyridine compounds that showed exceptional anti-rsv potency in cell culture. however, unfavorable pharmacokinetic (pk) properties and glutathione (gsh) adduct liabilities impeded their further development. in a bid to address the pk and early safety concerns, a small compound library consisting of dozens of scaffold-hopping analogues was designed and synthesized for rsv cpe assay screening, which led to the identification of a new chemical starting p ... | 2017 | 28772235 |
| converting everolimus to mycophenolate mofetil ameliorated prolonged respiratory syncytial virus infection in a child after heart transplantation. | in immunocompromised patients, respiratory syncytial virus (rsv) infections are known to be severe and prolonged, and have significant mortality and morbidity. however, little is known about the clinical courses and treatment strategy of rsv infection in heart transplant recipients. here, we report a 6-year-old female with heart transplantation who had exhibited prolonged respiratory symptoms and shedding of rsv. she had received everolimus as an immunosuppressant. as immunosuppressants could ha ... | 2017 | 28775087 |
| burden of lower respiratory infections in the eastern mediterranean region between 1990 and 2015: findings from the global burden of disease 2015 study. | we used data from the global burden of disease 2015 study (gbd) to calculate the burden of lower respiratory infections (lris) in the 22 countries of the eastern mediterranean region (emr) from 1990 to 2015. | 2017 | 28776246 |
| pneumonia with bacterial and viral coinfection. | we aim to review the epidemiology of pneumonia with bacterial and viral coinfection, the pathogenesis and clinical impact of coinfection along with the current state of treatment and outcomes. | 2017 | 28777158 |
| deep sequencing of rsv from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics. | as rna virus mutation occurs during replication within host cells, we hypothesized that viral evolution during acute infections in healthy hosts reflects host immune pressure. we therefore investigated the within-host diversification of human respiratory syncytial virus (rsv), a highly prevalent cause of acute respiratory infections. we evaluated healthy adults experimentally infected with an identical inoculum and infants hospitalized with naturally acquired infections. in aggregate, viral dive ... | 2017 | 28779686 |
| local dornase alfa treatment reduces nets-induced airway obstruction during severe rsv infection. | respiratory syncytial virus (rsv) infection is characterised by airway obstruction with mucus plugs, containing dna networks in the form of neutrophil extracellular traps (nets). we investigated the effect of dornase alfa on histopathological nets-induced airway obstruction and viral load in an age-relevant calf model of severe bovine rsv disease. as compared with the control animals, dornase alfa treatment resulted in a strong reduction of nets-induced airway obstruction. viral load in the lowe ... | 2017 | 28780505 |
| respiratory viral infections occurring after hematopoietic stem cell transplantation. | respiratory viral infection is one of the most crucial complications after hematopoietic stem cell transplantation (hsct), which affects approximately 60% of hsct recipients within one year after transplantation. prevalence of progression from upper respiratory tract infection to lower respiratory tract disease (lrd) among hsct recipients is 15-20% and day-90 mortality after lrd is as high as 40%. risk factors for the progression to lrd are early infection after hsct, low neutrophil or lymphocyt ... | 2017 | 28781280 |
| respiratory syncytial virus: the influence of serotype and genotype variability on clinical course of infection. | respiratory syncytial virus (rsv) belongs to the recently defined pneumoviridae family, orthopneumovirus genus. it is the leading cause of acute bronchiolitis and one of the most common causes of infant viral death worldwide, with infection typically occurring as recurrent seasonal epidemics. there are two major rsv subtypes, a and b, and multiple genotypes, which can coexist during rsv epidemic season every year and result in different disease severity. recently, new rsv genomic sequences and a ... | 2017 | 28783078 |
| is immunoprophylaxis with palivizumab justified for respiratory syncytial virus? | 2017 | 28783400 | |
| platelets modulate innate immune response against human respiratory syncytial virus in vitro. | detection of respiratory syncytial virus (rsv) in blood, including mononuclear leukocytes and organs other than the lung, suggests that rsv disseminates outside the respiratory tract. in this study, the role of platelets in host defense against rsv was explored using an in vitro model. platelets, also produced in the lungs, are increasingly recognized as an important part of host immune responses and may therefore play a role in modulating lung infections and clearing rsv viremia. in human perip ... | 2017 | 28783457 |
| in vitro enhancement of rsv infection by maternal antibodies does not explain disease severity in infants. | respiratory syncytial virus (rsv) is the leading cause of severe respiratory illness in infants. at this young age, infants typically depend on maternally transferred antibodies (matabs) and their innate immune system for protection against infections. rsv-specific matabs are thought to protect from severe illness, yet severe rsv disease occurs mainly below 6 months of age, when neutralizing matab levels are present. to investigate this discrepancy, we asked if disease severity is related to ant ... | 2017 | 28794038 |
| the epidemiology of medically attended respiratory syncytial virus in older adults in the united states: a systematic review. | this review was undertaken to assess the historical evidence of the disease incidence and burden of laboratory-confirmed respiratory syncytial virus (rsv) in medically attended older adults. | 2017 | 28797053 |
| propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures. | leading etiologies of acute illnesses, respiratory viruses typically cause self-limited diseases, though severe complications can occur in fragile patients. rhinoviruses, respiratory enteroviruses, influenza virus, respiratory syncytial viruses and coronaviruses are highly prevalent respiratory pathogens, but due to the lack of reliable animal models, their differential pathogenesis remains poorly characterized. | 2017 | 28797733 |
| new insights contributing to the development of effective vaccines and therapies to reduce the pathology caused by hrsv. | human respiratory syncytial virus (hrsv) is one of the major causes of acute lower respiratory tract infections (alrti) worldwide, leading to significant levels of immunocompromisation as well as morbidity and mortality in infants. its main target of infection is the ciliated epithelium of the lungs and the host immune responses elicited is ineffective at achieving viral clearance. it is thought that the lack of effective immunity against hrsv is due in part to the activity of several viral prot ... | 2017 | 28800119 |
| burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for england. | vaccines and prophylactic antibodies against respiratory syncytial virus (rsv) are in development and likely to be available in the next 5-10 years. the most efficient way to use these products when they become available is an important consideration for public health decision makers. | 2017 | 28804787 |
| the impact of the recent aap changes in palivizumab authorization on rsv-induced bronchiolitis severity and incidence. | following the most recent modification by the american academy of pediatrics, based on american studies on rsv epidemiology, the italian drug agency (aifa) decided to limit the total financial coverage of the palivizumab prescription by the national health service only to the < 29 wga group and age ≤ 12 months at the beginning of the rsv epidemic season. however, the vulnerability of otherwise healthy premature infants ≥ 29 wga has been demonstrated in italian analyses. we retrospectively review ... | 2017 | 28807039 |
| advances in vaccines to prevent viral respiratory illnesses in children. | childhood vaccination has played a critical role in the reduction of morbidity and mortality from communicable diseases, including specific respiratory pathogens. acute lower respiratory infection (alri) of both bacterial and viral aetiology continues to impact global child health. key bacterial pathogens including streptococcus pneumoniae and haemophilus influenza type b are specifically targeted with current vaccination programmes, while at present there are less effective strategies for the p ... | 2017 | 28808938 |
| innate lymphoid cells: the role in respiratory infections and lung tissue damage. | innate lymphoid cells (ilcs) represent a diverse family of cells of the innate immune system, which play an important role in regulation of tissue homeostasis, immunity and inflammation. emerging evidence has highlighted the importance of ilcs in both protective immunity to respiratory infections and their pathological roles in the lungs. therefore, the aim of this review is to summarize the current knowledge, interpret and integrate it into broader perspective, enabling greater insight into the ... | 2017 | 28812393 |
| bronchiolitis in infants and children. | bronchiolitis is among the most common illnesses in infants and children, and is the most common cause for hospitalization in infants in the u.s. this illness can be caused by many viruses, most commonly respiratory syncytial virus. it is diagnosed clinically by history and physical exam findings, with a narrow role for ancillary testing. management is supportive, with medications demonstrating limited utility in multiple studies. preventive measures include hand hygiene, breastfeeding, avoiding ... | 2017 | 28813765 |
| structure properties and mechanisms of action of naturally originated phenolic acids and their derivatives against human viral infections. | a great effort has been made to develop efficacious antiviral drugs, but many viral infections are still lack of efficient antiviral therapies so far. the related exploration of natural products to fight viruses has been raised in recent years. natural compounds with structural diversity and complexity offer a great chance to find new antiviral agents. particularly, phenolic acids have attracted considerable attention owing to their potent antiviral abilities and unique mechanisms. the aim of th ... | 2017 | 28814240 |
| bronchiolitis care in the hospital. | viral bronchiolitis is a common cause of hospitalization in young children, but despite a variety of therapeutic options, the mainstay of treatment remains supportive care. | 2017 | 28814254 |
| role of γδ t cells in exacerbated airway inflammation during reinfection of neonatally primed mice in adulthood. | age at primary infection with respiratory syncytial virus (rsv) is a crucial factor in determining the outcome of reinfection. however, how neonatal rsv infection affects the immune system and renders the host more susceptible to reinfection in later life is poorly understood. in the present study, by using balb/c mice that were first infected with rsv as neonates, the role of γδ t cells in the development of airway inflammation during reinfection in adulthood was investigated. we found that neo ... | 2017 | 28815644 |
| respiratory syncytial virus (rsv) entry is inhibited by serine protease inhibitor aebsf when present during an early stage of infection. | host proteases have been shown to play important roles in many viral activities such as entry, uncoating, viral protein production and disease induction. therefore, these cellular proteases are putative targets for the development of antivirals that inhibit their activity. host proteases have been described to play essential roles in ebola, hcv, hiv and influenza, such that specific protease inhibitors are able to reduce infection. rsv utilizes a host protease in its replication cycle but its po ... | 2017 | 28818113 |
| [lower lymphocyte response in severe cases of acute bronchiolitis due to respiratory syncytial virus]. | acute bronchiolitis (ab) of the infant has a serious outcome in 6-16% of the hospital admitted cases. its pathogenesis and evolution is related to the response of the t lymphocytes. the objective of the present study is to determine if the lower systemic lymphocytic response is related to a worse outcome of ab in hospitalised infants. | 2017 | 28818563 |
| multi-center evaluation of the cobas(®) liat(®) influenza a/b & rsv assay for rapid point of care diagnosis. | point of care testing (poct) provides the capability for rapid laboratory test results in patient care environments where a traditional clinical laboratory is not available. pocts have shorter turn-around times (tats), they may be performed by non-laboratory personnel, and the need for transport time is eliminated. the food and drug administration (fda) recently granted clinical laboratory improvements amendment (clia) waiver status to the cobas(®) influenza a/b & rsv assay, a rapid, accurate po ... | 2017 | 28818691 |
| qingkailing injection () for treatment of children pneumonia induced by respiratory syncytial virus: a meta-analysis of randomized controlled trials. | to evaluate the efficacy and safety of qingkailing injection (, qkl) for treatment of children pneumonia caused by respiratory syncytial virus (rsv). | 2017 | 28819777 |
| [clinical analysis of children with pertussis and significance of respiratory virus detection in the combined diagnosis]. | objective: to analyze the clinical data of children with pertussis and explore the necessity of respiratory virus detection in the combined diagnosis so as to improve the clinician's understanding and standardize the diagnosis and treatment of pertussis in children. method: clinical data and laboratory examination of 195 suspected pertussis children between jan. 2015 and dec. 2016 in children's hospital affiliated to capital institute of pediatric were analyzed retrospectively. result: the nasop ... | 2017 | 28822432 |
| [molecular biological and clinical characteristics of respiratory syncytial virus in children with bronchiolitis]. | objective: to investigate the clinical characteristics of respiratory syncytial virus(rsv)bronchiolitis and molecular biological characteristics of rsv in children in beijing. method: in a systematic retrospective study, 2 296 nasopharyngeal aspirates (npa) were collected from children diagnosed with bronchiolitis from july 2006 to june 2016 for respiratory virus screening using direct immunofluorescence assay (dfa). for specimens positive for rsv, subgroup a or b was confirmed by real time rt-p ... | 2017 | 28822433 |
| the crucial role of maternal care providers as vaccinators for pregnant women. | vaccination during pregnancy is increasingly being recognised internationally a useful means of preventing illness in pregnant women and their newborns. it has been used since the 1960s, when it was found that tetanus vaccine was highly effective in preventing neonatal tetanus, but interest has greatly increased over the last few years. as new data become available showing the numerous benefits of maternal immunisation and its potential for improving maternal and neonatal health in relation to a ... | 2017 | 28822646 |
| intranasal immunization with a single dose of the fusion protein formulated with a combination adjuvant induces long-term protective immunity against respiratory syncytial virus. | respiratory syncytial virus (rsv) is the most common cause of respiratory tract infections in both children and elderly people. in this study we evaluated the short- and long-term protective efficacy of a single intranasal (in) immunization with a rsv vaccine formulation consisting of a codon-optimized fusion (f) protein formulated with poly(i:c), an innate defense regulator peptide and a polyphosphazene (δf/triadj). this vaccine induced strong systemic and local immune responses, including rsv ... | 2017 | 28825870 |
| pneumopericardium, pneumomediastinum, and pneumorrachis complicating acute respiratory syncytial virus bronchiolitis in children. | we report 2 children with respiratory syncytial virus (rsv) infection complicated with spontaneous pneumopericardium (pp) and pneumomediastinum (pm), one also associated with pneumorrhachis (pr). | 2017 | 28829494 |
| evaluation of anyplex™ ii rv16 and rb5 real-time rt-pcr compared to seeplex(®) rv15 onestep ace and pneumobacter ace for the simultaneous detection of upper respiratory pathogens. | this prospective study was performed to evaluate and compare the performance of the multiplex pcr seeplex(®) assays and anyplex™ ii assays. from may 2014 until april 2016, a total of 247 respiratory samples were collected in okinawa, japan. multiple respiratory pathogens were detected in 37% of patients with positive results. the most prevalent pathogens were influenza a virus and respiratory syncytial virus b. despite minor differences in capabilities, both the seeplex(®) assays and anyplex™ ii ... | 2017 | 28830668 |
| chest radiographic features of human metapneumovirus infection in pediatric patients. | human metapneumovirus (hmpv) was identified in 2001 and is a common cause of acute respiratory illness in young children. the radiologic characteristics of laboratory-confirmed hmpv acute respiratory illness in young children have not been systematically assessed. | 2017 | 28831577 |
| detection of respiratory syncytial virus (rsv) at birth in a newborn with respiratory distress. | respiratory syncytial virus (rsv) is the most common respiratory pathogen in infants and young children. from the nasopharyngeal or conjunctival mucosa of infected individuals, rsv spreads to the lower respiratory tract causing acute bronchiolitis and pneumonia after an incubation period of 4-6 days. in addition to its well-documented tropism for the airway epithelium, it has been shown previously that rsv can also spread hematogenously and efficiently infect extrapulmonary tissues of human host ... | 2017 | 28834426 |
| attenuated human parainfluenza virus type 1 (hpiv1) expressing the respiratory syncytial virus (rsv) fusion f glycoprotein from an added gene: effects of pre-fusion stabilization and packaging of rsv f. | human respiratory syncytial virus (rsv) is the most prevalent worldwide cause of severe respiratory tract infection in infants and young children. human parainfluenza virus type 1 (hpiv1) also causes severe pediatric respiratory illness, especially croup. both viruses lack vaccines. here, we describe the preclinical development of a bivalent rsv/hpiv1 vaccine based on a recombinant hpiv1 vector, attenuated by a stabilized mutation, that expresses rsv f protein modified for increased stability in ... | 2017 | 28835504 |
| the burden of human metapneumovirus and respiratory syncytial virus infections in hospitalized norwegian children. | the burden of severe human metapneumovirus (hmpv) respiratory tract infections (rtis) in european children has not been clarified. we assessed hmpv in norwegian children and compared hospitalization rates for hmpv and respiratory syncytial virus (rsv). | 2017 | 28838133 |
| complete genome sequence of human respiratory syncytial virus from lanzhou, china. | a complete genome of human respiratory syncytial virus was sequenced and analyzed. phylogenetic analysis showed that the full-length human respiratory syncytial virus (hrsv) genome sequence belongs to gene type na1. we sequenced the genome in order to create the full-length cdna infectious clone and develop vaccines against hrsv. | 2017 | 28839014 |
| acute respiratory infections in hospitalized children in vientiane, lao pdr - the importance of respiratory syncytial virus. | the human respiratory syncytial virus (rsv) is one of the most important viral pathogens, causing epidemics of acute respiratory infection (ari), especially bronchiolitis and pneumonia, in children worldwide. to investigate the rsv burden in laos, we conducted a one-year study in children <5 years old admitted to mahosot hospital, vientiane capital, to describe clinical and epidemiological characteristics and predictive factors for severity of rsv-associated ari. pooled nasal and throat swabs we ... | 2017 | 28839157 |
| the impact of commercial rapid respiratory virus diagnostic tests on patient outcomes and health system utilization. | introduction acute respiratory tract infections due to influenza a/b and respiratory syncytial virus (rsv) are major causes of morbidity and mortality globally. rapid tests for detection of these pathogens include antigen detection point of care tests (poc) and newer easy to use molecular tests. from experience, these assays improve both laboratory workflow and assay interpretation issues. however, the question of the benefits of using rapid test technology compared to routine laboratory testing ... | 2017 | 28841814 |
| a49 molecular evolutionary dynamics of respiratory syncytial virus group a in recurrent epidemics in coastal kenya. | 2017 | 28845262 | |
| virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus. | formalin inactivated respiratory syncytial virus (fi-rsv) vaccination caused vaccine-enhanced respiratory disease (erd) upon exposure to rsv in children. virus-like particles presenting rsv f fusion protein (f vlp) are known to increase t helper type-1 (th1) immune responses and avoid erd in animal models. we hypothesized that f vlp would prime immune responses preventing erd upon subsequent exposure to erd-prone fi-rsv. here, we demonstrated that heterologous f vlp priming and fi-rsv boosting o ... | 2017 | 28846899 |
| peptidoglycan from immunobiotic lactobacillus rhamnosus improves resistance of infant mice to respiratory syncytial viral infection and secondary pneumococcal pneumonia. | several research works have demonstrated that beneficial microbes with the capacity to modulate the mucosal immune system (immunobiotics) are an interesting alternative to improve the outcome of bacterial and viral respiratory infections. among the immunobiotic strains with the capacity to beneficially modulate respiratory immunity, lactobacillus rhamnosus crl1505 has outstanding properties. although we have significantly advanced in demonstrating the capacity of l. rhamnosus crl1505 to improve ... | 2017 | 28848552 |
| human genetic determinants of viral diseases. | much progress has been made in the identification of specific human gene variants that contribute to enhanced susceptibility or resistance to viral diseases. herein we review multiple discoveries made with genome-wide or candidate gene approaches that have revealed significant insights into virus-host interactions. genetic factors that have been identified include genes encoding virus receptors, receptor-modifying enzymes, and a wide variety of innate and adaptive immunity-related proteins. we d ... | 2017 | 28853921 |
| soluble f proteins exacerbate pulmonary histopathology after vaccination upon respiratory syncytial virus challenge but not when presented on virus-like particles. | respiratory syncytial virus (rsv) fusion (f) protein is suggested to be a protective vaccine target although its efficacy and safety concerns remain not well understood. we investigated immunogenicity, efficacy, and safety of f proteins in a soluble form or on virus-like particle (f-vlp). f vlp preferentially elicited igg2a antibody and t helper type 1 (th1) immune responses whereas f protein induced igg1 isotype and th2 responses. despite lung viral clearance after prime or prime-boost and then ... | 2017 | 28854003 |
| respiratory syncytial virus infection influences tight junction integrity. | background respiratory syncytial virus (rsv) is an important risk factor of asthma development and is responsible for severe respiratory tract infections. however, the influence of rsv infection on barrier function of bronchial epithelial cells in vitro and in vivo is still unclear. objective the aim of this study was to analyze the role of rsv in tight junction (tj) regulation and to compare epithelial integrity between asthmatic and healthy individuals upon rsv infection. methods healthy and a ... | 2017 | 28856667 |
| reduced activation and proliferation of human lymphocytes exposed to respiratory syncytial virus compared to cells exposed to influenza virus. | both respiratory syncytial virus (rsv) and influenza a virus (iav) may infect human peripheral blood mononuclear leukocytes (pbmc) during the immune response to viral challenge as the cells are recruited to the respiratory tract. the current studies demonstrated differences in pbmc responses to the two viruses very early after exposure, including reduced fos protein and cd69 expression and il-2 production by rsv-exposed t lymphocytes. exposure to rsv resulted in reduced lymphocyte proliferation ... | 2017 | 28856681 |
| determining the seasonality of respiratory syncytial virus in the united states: the impact of increased molecular testing. | in the united states, the seasonality of respiratory syncytial virus (rsv) has traditionally been defined on the basis of weeks during which antigen-based tests detect rsv in >10% of specimens (hereafter, the "10% threshold"). because molecular testing has become more widely used, we explored the extent of polymerase chain reaction (pcr)-based rsv testing and its impact on determining the seasonality of rsv. | 2017 | 28859428 |
| viral bronchiolitis in young infants: new perspectives for management and treatment. | the aim of this review was to address advances in management and treatment of acute viral bronchiolitis in infants. | 2017 | 28859915 |
| modulation of host immunity by human respiratory syncytial virus virulence factors: a synergic inhibition of both innate and adaptive immunity. | the human respiratory syncytial virus (hrsv) is a major cause of acute lower respiratory tract infections (artis) and high rates of hospitalizations in children and in the elderly worldwide. symptoms of hrsv infection include bronchiolitis and pneumonia. the lung pathology observed during hrsv infection is due in part to an exacerbated host immune response, characterized by immune cell infiltration to the lungs. hrsv is an enveloped virus, a member of the pneumoviridae family, with a non-segment ... | 2017 | 28861397 |
| data describing ifnγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (rsv). | the data presented here are related to the research article entitled "age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of ifnγ and gm-csf in a mouse model of rsv infection" (eichinger et al., 2017) [1]. the cited manuscript demonstrated that the macrophage-stimulating cytokine, interferon gamma (ifnγ), but not granulocyte macrophage-colony stimulating factor (gm-csf), effectively enhanced viral clearance in infant mice infected with respiratory syncy ... | 2017 | 28861450 |